2017
DOI: 10.4172/2157-7439.1000474
|View full text |Cite
|
Sign up to set email alerts
|

Cerium Oxide Nanoparticles as Novel Tool in Glioma Treatment: An In vitro Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 70 publications
0
5
0
Order By: Relevance
“…Results showed that CeO-NPs induced apoptosis in cancer cells but not in normal tissues and reduced tumor growth and invasiveness in a xenograft animal model in vivo [20]. CeO-NPs were also effective in killing high-grade astrocytoma cells but not normal endothelial cells, which were inhibited in their migratory capacity, suggesting that tumor angiogenesis might also be effectively targeted by this treatment [21]. In addition, CeO-NPs were also used in combination with the anticancer compound doxorubicin, which exerts its cytotoxic effect in part by inducing ROS [12].…”
Section: Modulation Of Redox Homeostasis By Nanoparticlesmentioning
confidence: 99%
“…Results showed that CeO-NPs induced apoptosis in cancer cells but not in normal tissues and reduced tumor growth and invasiveness in a xenograft animal model in vivo [20]. CeO-NPs were also effective in killing high-grade astrocytoma cells but not normal endothelial cells, which were inhibited in their migratory capacity, suggesting that tumor angiogenesis might also be effectively targeted by this treatment [21]. In addition, CeO-NPs were also used in combination with the anticancer compound doxorubicin, which exerts its cytotoxic effect in part by inducing ROS [12].…”
Section: Modulation Of Redox Homeostasis By Nanoparticlesmentioning
confidence: 99%
“…CeO‐NPs were found to cause apoptosis in cancer cells but not in healthy tissues, and to inhibit the growth and metastatic spread of cancer in an animal model of xenografts in vivo (Alili et al, 2013). CeO‐NPs effectively inhibited the motility of normal endothelial cells while damaging elevated astrocytoma cells, suggesting that this drug may also be helpful in halting tumor angiogenesis (Zschauer et al, 2017). CeO‐NPs improved the anticancer effects of doxorubicin while dramatically lowering the adverse effects of this medicine on normal cells, including myocardiocytes, in line with its dual impact on ROS in cancer vs. normal tissues.…”
Section: Mechanistic Framework Of Ne‐pdtmentioning
confidence: 99%
“…Some previous reports show that CeO 2 has different results to different cells due to different intracellular environments such as the concentration of intercellular hydroxyl radicals [15,[58][59][60]. For example, Sack-Zschauer et al found that cerium oxide nanoparticles have a cytotoxicity to astrocytoma cells while showing no cytotoxicity towards endothelial cells [61]. Khaligh et al synthesized two materials, which are toxic to human HT-29 colon cancer cells line but not to human foreskin fibroblast cells line [62].…”
Section: Effect Of Materials Concentration On Antioxidant Activitymentioning
confidence: 99%